Sociodemographic, Clinical, and Psychosocial Characteristics of People with Hemophilia in Portugal: Findings from the First National Survey

 

 Permissions and Reprints

Abstract

Hemophilia is a rare genetic bleeding disorder associated with pain, impaired functionality, and decreased quality of life (QoL). Several studies have focused on patient-reported outcomes of people with hemophilia (PWH) worldwide, but no such data are available for Portugal. This survey aimed to describe sociodemographic, clinical, and psychosocial characteristics of PWH of all ages in Portugal. Questionnaires were answered by self-report or by parents of children with hemophilia (proxy version). Variables assessed were sociodemographic and clinical, physical activity patterns, pain, functionality (HAL/PedHAL), QoL (A36 Hemofilia-QoL/CHO-KLAT), anxiety and depression (PROMIS), and illness perceptions (IPQ-R). One-hundred and forty-six PWH answered the survey: 106 adults, 21 children/teenagers between 10 and 17 years, 11 children between 6 and 9 years, and 8 children between 1 and 5 years. Most participants had severe hemophilia (60.3%) and type A was most commonly reported (86.3%). Bleeding episodes, joint deterioration, and pain were very prevalent, with the ankles and knees being the most affected joints, as illustrated by HAL/PedHAL scores. The A36 Hemofilia-QoL assessment showed moderate QoL (96.45; 0–144 scale) and significant anxiety and depression symptoms were found in 36.7 and 27.2% of adults, respectively. CHO-KLAT global score (0–100 scale) was 75.63/76.32 (self-report/proxy). Concerning hemophilia-related illness beliefs, a perception of chronicity and symptoms unpredictability was particularly prominent among adults and children/teenagers. This survey provided a comprehensive characterization of Portuguese PWH, including the first report of psychosocial characteristics. The findings allow for a deeper understanding of life with hemophilia in Portugal and the identification of relevant health care and research needs.

Authors' Contributions

All authors had full access do data and participated in the preparation of this manuscript. All authors approved the final version and are accountable for any issue regarding the accuracy and integrity of the work.

• References

• 1 Bolton-Maggs PH, Pasi KJ. Haemophilias A and B. Lancet 2003; 361 (9371): 1801-1809
  CrossrefPubMedGoogle Scholar
• 2 White II GC, Rosendaal F, Aledort LM, Lusher JM, Rothschild C, Ingerslev J. ; Factor VIII and Factor IX Subcommittee. Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 2001; 85 (03) 560
  Article in Thieme ConnectPubMedGoogle Scholar
• 3 Valentino LA. Blood-induced joint disease: the pathophysiology of hemophilic arthropathy. J Thromb Haemost 2010; 8 (09) 1895-1902
  CrossrefPubMedGoogle Scholar
• 4 Manco-Johnson MJ, Soucie JM, Gill JC. ; Joint Outcomes Committee of the Universal Data Collection, US Hemophilia Treatment Center Network. Prophylaxis usage, bleeding rates, and joint outcomes of hemophilia, 1999 to 2010: a surveillance project. Blood 2017; 129 (17) 2368-2374
  PubMedGoogle Scholar
• 5 Srivastava A, Brewer AK, Mauser-Bunschoten EP. , et al; Treatment Guidelines Working Group on Behalf of The World Federation Of Hemophilia. Guidelines for the management of hemophilia. Haemophilia 2013; 19 (01) e1-e47
  CrossrefPubMedGoogle Scholar
• 6 Coppola A, Franchini M, Tagliaferri A. Prophylaxis in people with haemophilia. Thromb Haemost 2009; 101 (04) 674-681
  Article in Thieme ConnectPubMedGoogle Scholar
• 7 Pocoski J, Benjamin K, Michaels LA, Flood E, Sasane R. An overview of current trends and gaps in patient-reported outcome measures used in haemophilia. Eur J Haematol 2014; 93 (Suppl. 75) 1-8
  CrossrefPubMedGoogle Scholar
• 8 Bossard D, Carrillon Y, Stieltjes N. , et al. Management of haemophilic arthropathy. Haemophilia 2008; 14 (Suppl. 04) 11-19
  PubMedGoogle Scholar
• 9 Nugent DJ, Guelcher C, Forsyth A. , et al. Hemophilia Experiences, Results and Opportunities (HERO) Study: US respondent demographics and impact of diagnosis on career and lifestyle decisions and quality of life [Abstract]. Blood 2012; 120 (21) 4244
  PubMedGoogle Scholar
• 10 Soucie JM, Grosse SD, Siddiqi AE. , et al; Hemophilia Treatment Centers Network. The effects of joint disease, inhibitors and other complications on health-related quality of life among males with severe haemophilia A in the United States. Haemophilia 2017; 23 (04) e287-e293
  CrossrefPubMedGoogle Scholar
• 11 Hermans C, Klamroth R, Richards M, de Moerloose P, Garrido RP. ; EHTSB. Outcome measures in European patients with haemophilia: Survey of implementation in routine clinical practice, perception of relevance and recommendations by European treaters in the EHTSB. Haemophilia 2017; 23 (02) 222-229
  CrossrefPubMedGoogle Scholar
• 12 Cassis FR, Buzzi A, Forsyth A. , et al. Haemophilia Experiences, Results and Opportunities (HERO) Study: influence of haemophilia on interpersonal relationships as reported by adults with haemophilia and parents of children with haemophilia. Haemophilia 2014; 20 (04) e287-e295
  CrossrefPubMedGoogle Scholar
• 13 Plug I, Peters M, Mauser-Bunschoten EP. , et al. Social participation of patients with hemophilia in the Netherlands. Blood 2008; 111 (04) 1811-1815
  CrossrefPubMedGoogle Scholar
• 14 World Federation of Haemophilia. Report on the Annual Global Survey 2015. Available at: http://www1.wfh.org/publication/files/pdf-1669.pdf . Accessed January 19, 2017
  PubMedGoogle Scholar
• 15 Remor E, Arranz P, Quintana M. , et al; Hemofilia-QoL Project Group. Psychometric field study of the new haemophilia quality of life questionnaire for adults: the ‘Hemofilia-QoL’. Haemophilia 2005; 11 (06) 603-610
  CrossrefPubMedGoogle Scholar
• 16 Young NL, Bradley CS, Blanchette V. , et al. Development of a health-related quality of life measure for boys with haemophilia: the Canadian Haemophilia Outcomes--Kids Life Assessment Tool (CHO-KLAT). Haemophilia 2004; 10 (01) (Suppl. 01) 34-43
  PubMedGoogle Scholar
• 17 van Genderen FR, Westers P, Heijnen L. , et al. Measuring patients' perceptions on their functional abilities: validation of the Haemophilia Activities List. Haemophilia 2006; 12 (01) 36-46
  PubMedGoogle Scholar
• 18 Groen WG, van der Net J, Helders PJ, Fischer K. Development and preliminary testing of a Paediatric Version of the Haemophilia Activities List (pedhal). Haemophilia 2010; 16 (02) 281-289
  CrossrefPubMedGoogle Scholar
• 19 Pilkonis PA, Choi SW, Reise SP, Stover AM, Riley WT, Cella D. ; PROMIS Cooperative Group. Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS®): depression, anxiety, and anger. Assessment 2011; 18 (03) 263-283
  CrossrefPubMedGoogle Scholar
• 20 Kroenke K, Yu Z, Wu J, Kean J, Monahan PO. Operating characteristics of PROMIS four-item depression and anxiety scales in primary care patients with chronic pain. Pain Med 2014; 15 (11) 1892-1901
  CrossrefPubMedGoogle Scholar
• 21 Moss-Morris R, Weinman J, Petrie K. , et al. The Revised Illness Perception Questionnaire (IPQ-R). Psychol Health 2002; 17 (01) 1-16
  CrossrefPubMedGoogle Scholar
• 22 National Statistics Institute. Taxa de desemprego da população ativa com idade entre 15 e 74 anos por Sexo; Mensal – Setembro 2017. Lisboa: INE. Available at: https://www.ine.pt/xportal/xmain?xpid=INE&xpgid=ine_indicadores&indOcorrCod=0007975&contexto=bd&selTab=tab2
  PubMedGoogle Scholar
• 23 Cutter S, Molter D, Dunn S. , et al. Impact of mild to severe hemophilia on education and work by US men, women, and caregivers of children with hemophilia B: The Bridging Hemophilia B Experiences, Results and Opportunities into Solutions (B-HERO-S) study. Eur J Haematol 2017; 98 (86) (Suppl. 86) 18-24
  CrossrefPubMedGoogle Scholar
• 24 Forsyth AL, Gregory M, Nugent D. , et al. Haemophilia Experiences, Results and Opportunities (HERO) Study: survey methodology and population demographics. Haemophilia 2014; 20 (01) 44-51
  CrossrefPubMedGoogle Scholar
• 25 Cassis FR, Querol F, Forsyth A, Iorio A. ; HERO International Advisory Board. Psychosocial aspects of haemophilia: a systematic review of methodologies and findings. Haemophilia 2012; 18 (03) e101-e114
  CrossrefPubMedGoogle Scholar
• 26 Shapiro AD, Donfield SM, Lynn HS. , et al; Academic Achievement in Children with Hemophilia Study Group. Defining the impact of hemophilia: the Academic Achievement in Children with Hemophilia Study. Pediatrics 2001; 108 (06) E105
  CrossrefPubMedGoogle Scholar
• 27 Steen Carlsson K, Höjgård S, Glomstein A. , et al. On-demand vs. prophylactic treatment for severe haemophilia in Norway and Sweden: differences in treatment characteristics and outcome. Haemophilia 2003; 9 (05) 555-566
  CrossrefPubMedGoogle Scholar
• 28 Fischer K, Steen Carlsson K, Petrini P. , et al. Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s. Blood 2013; 122 (07) 1129-1136
  CrossrefPubMedGoogle Scholar
• 29 Iannone M, Pennick L, Tom A. , et al. Prevalence of depression in adults with haemophilia. Haemophilia 2012; 18 (06) 868-874
  CrossrefPubMedGoogle Scholar
• 30 PORDATA. Retrato de Portugal na Europa. 2017. Lisboa: Fundação Francisco Manuel dos Santos. Available at: http://www.pordata.pt/ebooks/PT2017v20171012/mobile/index.html#p=2 . Accessed December 26, 2017
  PubMedGoogle Scholar
• 31 Osooli M, Lövdahl S, Steen Carlsson K. , et al. Comparative burden of arthropathy in mild haemophilia: a register-based study in Sweden. Haemophilia 2017; 23 (02) e79-e86
  CrossrefPubMedGoogle Scholar
• 32 Nugent D, Kalnins W, Querol F. , et al. Haemophilia Experiences, Results and Opportunities (HERO) study: treatment-related characteristics of the population. Haemophilia 2015; 21 (01) e26-e38
  CrossrefPubMedGoogle Scholar
• 33 Mahony BO, Savini L, Hara JO, Bok A. Haemophilia care in Europe - A survey of 37 countries. Haemophilia 2017; 23 (04) e259-e266
  CrossrefPubMedGoogle Scholar
• 34 Witkop M, Neff A, Buckner TW. , et al. Self-reported prevalence, description and management of pain in adults with haemophilia: methods, demographics and results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study. Haemophilia 2017; 23 (04) 556-565
  CrossrefPubMedGoogle Scholar
• 35 Young G, Tachdjian R, Baumann K, Panopoulos G. Comprehensive management of chronic pain in haemophilia. Haemophilia 2014; 20 (02) e113-e120
  CrossrefPubMedGoogle Scholar
• 36 Halford J, Brown T. Cognitive–behavioural therapy as an adjunctive treatment in chronic physical illness. Adv Psychiatr Treat 2009; 15 (04) 306-317
  CrossrefPubMedGoogle Scholar
• 37 Schäfer GS, Valderramas S, Gomes AR, Budib MB, Wolff ÁL, Ramos AA. Physical exercise, pain and musculoskeletal function in patients with haemophilia: a systematic review. Haemophilia 2016; 22 (03) e119-e129
  CrossrefPubMedGoogle Scholar
• 38 Niu X, Poon JL, Riske B. , et al. Physical activity and health outcomes in persons with haemophilia B. Haemophilia 2014; 20 (06) 814-821
  CrossrefPubMedGoogle Scholar
• 39 European Commission. Special Eurobarometer 412 Sport and physical activity. Available at: http://ec.europa.eu/commfrontoffice/publicopinion/archives/ebs/ebs_412_en.pdf . Accessed June 15, 2017
  PubMedGoogle Scholar
• 40 von Mackensen S, Harrington C, Tuddenham E. , et al. The impact of sport on health status, psychological well-being and physical performance of adults with haemophilia. Haemophilia 2016; 22 (04) 521-530
  CrossrefPubMedGoogle Scholar
• 41 Groen WG, Takken T, van der Net J, Helders PJ, Fischer K. Habitual physical activity in Dutch children and adolescents with haemophilia. Haemophilia 2011; 17 (05) e906-e912
  CrossrefPubMedGoogle Scholar
• 42 McGee S, Raffini L, Witmer C. Organized sports participation and the association with injury in paediatric patients with haemophilia. Haemophilia 2015; 21 (04) 538-542
  CrossrefPubMedGoogle Scholar
• 43 Carvalhosa AM, Henrard S, Lambert C, Hermans C. Physical and mental quality of life in adult patients with haemophilia in Belgium: the impact of financial issues. Haemophilia 2014; 20 (04) 479-485
  CrossrefPubMedGoogle Scholar
• 44 Walsh M, Macgregor D, Stuckless S, Barrett B, Kawaja M, Scully MF. Health-related quality of life in a cohort of adult patients with mild hemophilia A. J Thromb Haemost 2008; 6 (05) 755-761
  CrossrefPubMedGoogle Scholar
• 45 Lindvall K, Von Mackensen S, Berntorp E. Quality of life in adult patients with haemophilia--a single centre experience from Sweden. Haemophilia 2012; 18 (04) 527-531
  CrossrefPubMedGoogle Scholar
• 46 Poon JL, Zhou ZY, Doctor JN. , et al. Quality of life in haemophilia A: Hemophilia Utilization Group Study Va (HUGS-Va). Haemophilia 2012; 18 (05) 699-707
  CrossrefPubMedGoogle Scholar
• 47 Dolatkhah R, Fakhari A, Pezeshki MZ, Shabanlouei R, Tavassoli N, Gholchin M. Social determinants and health-related dimensions of quality of life in adult patients with haemophilia. Haemophilia 2014; 20 (03) 376-381
  CrossrefPubMedGoogle Scholar
• 48 Eshghi P, Mahdavi-Mazdeh M, Karimi M, Aghighi M. Haemophilia in the developing countries: the Iranian experience. Arch Med Sci 2010; 6 (01) 83-89
  PubMedGoogle Scholar
• 49 McCusker PJ, Fischer K, Holzhauer S. , et al. International cross-cultural validation study of the Canadian haemophilia outcomes: kids' life assessment tool. Haemophilia 2015; 21 (03) 351-357
  CrossrefPubMedGoogle Scholar
• 50 St-Louis J, Urajnik DJ, Ménard F. , et al. Generic and disease-specific quality of life among youth and young men with Hemophilia in Canada. BMC Hematol 2016; 16: 13
  CrossrefPubMedGoogle Scholar
• 51 Manco-Johnson M, Morrissey-Harding G, Edelman-Lewis B, Oster G, Larson P. Development and validation of a measure of disease-specific quality of life in young children with haemophilia. Haemophilia 2004; 10 (01) 34-41
  PubMedGoogle Scholar
• 52 Villaça PR, Blanchette VS, Carneiro JD. , et al. Validity of the Portuguese CHO-KLAT in Brazil. Haemophilia 2016; 22 (06) 894-897
  CrossrefPubMedGoogle Scholar
• 53 Buckner TW, Witkop M, Guelcher C. , et al. Impact of mild to severe hemophilia B on quality of life including pain and functional abilities in affected men/women and caregivers of affected boys/girls: analysis of patient reported outcomes in the Bridging Hemophilia B Experiences Results and Opportunities into Solutions (B-HERO-S) Study [Abstract]. Blood 2016; 128 (22) 251
  PubMedGoogle Scholar
• 54 Llewellyn CD, Miners AH, Lee CA, Christine H, Weinman J. The illness perceptions and treatment beliefs of individuals with severe haemophilia and their role in adherence to home treatment. Psychol Health 2003; 18 (02) 185-200
  CrossrefPubMedGoogle Scholar